Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Feb 3.
Published in final edited form as: Vaccine. 2015 Dec 29;34(6):791–797. doi: 10.1016/j.vaccine.2015.12.042

Nasopharyngeal Carriage of Streptococcus pneumoniae among Children in an Urban Setting in Brazil prior to PCV10 Introduction

Ana Paula de O Menezes 1, Jailton Azevedo 1, Mariela C Leite 2, Leila C Campos 1, Marcelo Cunha 3, Maria da Gloria S Carvalho 4, Mitermayer G Reis 1, Albert I Ko 1,5, Daniel M Weinberger 5, Guilherme Ribeiro 1,6, Joice N Reis 1,2,§
PMCID: PMC4729601  NIHMSID: NIHMS747378  PMID: 26742946

Abstract

Information on pneumococcal carriage in the pre-vaccine period is essential to predict and assess the impact of PCV in settings where disease surveillance is particularly difficult. Therefore, we present data on pneumococcal carriage before the introduction of the 10-valent-pneumococcal conjugate vaccine (PCV10) in Brazil. We conducted a prospective study on a cohort of 203 children aged < 5 years-old, randomly selected in an urban community located in the periphery of the city of Salvador, Brazil and followed them from January/2008 to January/2009. Nasopharyngeal swabs were collected from each child at four times. In total, 721 swabs were collected, yielding a pneumococcal carriage prevalence of 55% (n=398). In multivariate analyses, the variables associated with carriage were having contact with three or more children <2 years old (OR, 2.00; 95% CI 1.33–2.89) and living in a house with an average of 3 residents per room (OR, 1.77; 95% CI 1.05–3.10). Also, white participants were more likely to be protected from colonization (OR, 0.52; 95% CI 0.29–0.93), and prevalence of carriage varied over time, with lower prevalence occurring from February to June (OR, 0.53; 95% CI 0.37–0.78) compared to July to January. Contact with children under two years of age and living in crowded housing also were associated with colonization by highly invasive serotypes, although this relationship was not significant. The most prevalent vaccine serotypes were 6A/B (25.4%), 19F (10.1%) and 14 (9.0%), while the most prevalent non-vaccine serotypes were 16F (4.8%), 15B/C (4.5%) and 6C/D (3.5%). Overall, 38.4% (153/398) of the isolates were non-susceptible to penicillin, and of those, 73.8% (113/153) were non-susceptible to trimethoprim/sulfamethoxazole. Colonization rate by PCV10 serotypes was 52.2%. Routine PCV10 vaccination can lead to significant changes in pneumococcal serotypes found in NP colonization, indicating a need for continued monitoring, especially in crowded settings, as occurs in Brazil’s slums.

Keywords: Children, nasopharyngeal carriage, Streptococcus pneumoniae, serotypes, PCV10-vaccine

Background

Asymptomatic carriage of pneumococci is common in young children and has been related to the development of disease and transmission of the pathogen [13]. The prevalence of pneumococcal carriage increases in the first few years of life, peaking at approximately 50% to 80% in children 2–3 years of age and decreasing thereafter until stabilizing at 5% to 10% in children over 10 years of age [4]. Effective vaccines against 10-, or 13- of the more than 90 pneumococcal serotypes are now used in many countries, resulting in a substantial decline in invasive disease and carriage of vaccine serotypes [5, 6]. Despite this success, serotypes not targeted by the vaccine have increased among healthy carriers and could potentially become important causes of invasive diseases. As Brazil started nationwide vaccination with 10-valent pneumococcal conjugate vaccine (PCV10) in 2010, it is essential to have information on pneumococcal carriage in the pre-vaccine era to assess potential vaccine impact.

Many studies have been conducted in Brazil to investigate the distribution of pneumococcal serotypes from invasive disease and nasopharyngeal colonization. However, there are no reports of prospective studies conducted in communities. The previous studies were undertaken in schools and daycare settings, which represent important risk factors for the transmission and circulation of pneumococcus [7, 8]. In addition, a previous cross-sectional study that we conducted in a slum community in Salvador did not observe an association between prevalence of carriage with the size of the household or numbers of household contacts. It was hypothesized that study design and sample size could have affected the ability to adequately evaluate the effect of risk factors related to population or household density [9].

Thus, we carried out a cohort study of pneumococcal carriage in a slum community in Salvador to describe the risk factors for carrier status of S. pneumoniae in children under five years old. We also determined the distribution of serotypes, characterized antimicrobial susceptibility, and defined the possible coverage provided by the 10 or 13 valent pneumococcal conjugate vaccine (PCV10 or PCV13).

Methods

Study site and population

The study was conducted in the Pau da Lima community, which is situated in the periphery of Salvador, a city of 2.7 million inhabitants [10] in Northeast Brazil. We selected an area of 0.46 km2 where a cohort study for leptospirosis was conducted in 2003. As a part of this study, a census was completed during visits to 3,689 households; this identified 14,122 inhabitants, of which 8% (n=1, 131) were aged < 5 years [11]. A total of 130 households were randomly selected within the census tract in order to have 203 children < 5 years old enrolled in the study. This sample size was based on a previous study conducted in Salvador, where 65% of Children < 5 years were colonized at a single time-point [9]. Eligible subjects, defined as children 1 to 59 months of age who lived continuously in one of the selected households during the month prior to recruitment, were enrolled into the study according to informed consent procedures approved by the Oswaldo Cruz Foundation, Brazilian Ministry of Health.

Data collection

During house visits, a standardized questionnaire was used to document information on demographics, underlying medical conditions, hospitalizations, occurrence of an upper respiratory tract infection (URTI) in the previous month, antibiotic therapy in the last four weeks before the visit, childcare arrangements, school attendance and household inhabitants’ habits such as smoking. Information for children was obtained by interviewing the parent or legal guardian. Household crowding was defined as the number of people divided by the number of rooms in the house, or the number of people divided by the number of beds in the house. Household contact with children less than two years old was defined as contact of at least 4 hours per day.

Isolation of pneumococci

Between January 2008 and January 2009, nasopharyngeal swabs were collected from each child at four times, at enrollment and then again at three month intervals. Samples were collected with calcium alginate swabs (Calgiswab type 1, Spectrum USA) and inoculated into modified Stuart transport medium and sent to the Clinical Microbiology Laboratory at the Gonçalo Moniz Research Institute. All swabs were plated within 4 hours onto agar plates with 5% sheep blood and 5.0 µg/ mL of gentamicin. Plates were incubated at 35°C in 5% CO2-enriched atmosphere for up to 48 hours. Three α-hemolytic colonies exhibiting morphologic characteristics suggestive of S. pneumoniae were isolated. Identification of these isolates as S. pneumoniae was confirmed by optochin disc susceptibility (BBL Microbiology Systems, Cockeysville, USA) and the bile solubility test. One S. pneumoniae colony per plate was then sub-cultured, harvested, and kept frozen at −70 °C for further testing. When S. pneumoniae isolates from the same primary plate exhibited a clearly different colony morphology, dissimilar colonies were frozen separately.

Serotyping

The isolates were serotyped by multiplex-PCR as described elsewhere [12]. DNA extraction and PCR conditions were performed as described by the US Centers for Disease Control and Prevention (CDC) [12]. Isolates with negative multiplex PCR results were subjected to single-plex-PCR with primer 19F variation [13] and Quellung reaction testing for capsular type definition.

Antimicrobial susceptibility testing

The broth microdilution method was performed according to Clinical and Laboratory Standard Institute recommendations [14] to determine susceptibility of isolates to penicillin, cefotaxime, tetracycline, erythromycin, trimethoprim/sulfamethoxazole (TMP/SMX) and levofloxacin (Sigma–Aldrich, Germany). Quality control was performed by testing S. pneumoniae ATCC 49619. Isolates with a penicillin MIC value ≥ 0.12 µg/mL were defined as penicillin non-susceptible.

Genotyping

Pulse field gel electrophoresis (PFGE) analysis was performed to define the molecular profile of the isolates. Chromosomal digests generated by SmaI were prepared and analyzed as described elsewhere [15]. A CHEF DRII apparatus (Bio-Rad, Hercules, CA) was used for running the gels. The bacterial strains were also analyzed by multilocus sequence typing (MLST), as described elsewhere [16].

Data management and statistical analysis

Data were entered and managed by Epi Info version 3.5.1 (CDC, Atlanta, GA, USA). Statistical analyses were performed in SAS v9.3. Univariate and multivariate logistic regression models were constructed to identify risk factors for colonization (PROC GLIMMIX). To construct confidence intervals that accounted for the non-independence of samples from the same individual, we created 1000 bootstrap samples, where all observations from an individual were grouped together and sampled with replacement. Household crowding was analyzed as continuous variables. A variable was considered to be significantly associated with colonization (p<0.05) if the 95% CI did not include 1.

For multivariate models, variables that were significant in the univariate analyses were included in different combinations, with the best-fitting model determined by Akaike Information Criteria (AIC) [17]. To test for an association between the demographic risk factors and the odds of being colonized with a high or low-invasiveness serotype, we created three outcome categories: uncolonized, colonized with a high invasiveness serotype (4, 7F, 8, 9V, 14, 18C and 19A;), or colonized by a low-invasiveness serotype (3, 6A/B/C, 11A, 13, 15A, 15B/C, 16F, 17F, 19F, 20, 21, 22F, 23B, 23F, 35F and NT [Not Typeable]) [18]. We then fit univariate generalized logit models to these data and again used the bootstrap samples to test for significance at p=0.05.

Results

Demographic characteristics

In January 2008, a total of 203 children were enrolled into the cohort study. Ages ranged from 1 to 48 months, and the median age was 24 months (interquartile range: 12–36). There was a predominance of mixed race (70%), and 48% of participants were males. The families of the enrolled children reported low monthly income (less than USD$ 430.00), and crowded environments were observed in the households, with a median of five (range: 2 to 15) inhabitants per household. Most of the study children lived in households of two rooms (81.8%), with a ratio of 3.5 residents per bed (Table 1).

Table 1.

Risk Factors for pneumococcal carriage among children < 5 years old at community-level prior to PCV10 introduction in Brazil.

Demographic Characteristics N(%)a Pneumococcal Carriage - OR (95%CI)

Univariate Analysis Multivariate Analysis
Age (months)
  <6 50 (7%) REFb
  6–11 93 (13%) 0.62 (0.27 –1.41)
  12–23 145 (20%) 1.35 (0.64 – 2.91)
  24–35 132 (18%) 0.82 (0.38 – 1.70)
  36–47 173 (24%) 0.71 (0.35 – 1.42)
  48–59 128 (18%) 0.70 (0.32 – 1.49)
Gender Male 347 (48%) 1.03 (0.73 – 1.44)
Racea
  Mixed 505 (70%) REFb REFb
  White 59 (8%) 0.52 (0.30 – 0.90) 0.52 (0.29 – 0.93)
  Black 153 (21%) 0.77 (0.50 – 1.20)
Day care Attendance
  No 685 (96%)
  Yes 28 (4%) 1.40 (0.67–3.50)
URTI in the last month
  No 287 (40.5%) REFb REFb
  Yes 421 (59.5%) 1.42 (1.06–1.94) 1.38 (1.00 – 1.89)
Exposure to cigarette smoking
  No 490 (68%) REFb
  Yes 231 (32%) 1.11 (0.75 –1.67)
Antibiotic use in the last month
  No 653 (92%) REFb
  Yes 58 (8%) 0.90 (0.51 – 1.60)
Number of children ≤ 2 years living in the same household
  None 288 (40%) REFb REFb
  One contact 358 (50%) 1.60 (1.10 – 2.31) 1.44 (0.99 – 2.20)
  Two contacts 67 (9%) 1.90 (1.10 – 3.50) 1.38 (0.73 – 2.53)
  Three contacts 4 (1%) 3.20 (2.4 – 4.31) 2.00 (1.33 – 2.89)
No. of residents/No. of rooms 3.3 (±1.7) 1.90 (1.19–3.13) 1.77 (1.05 – 3.10)
No. of residents/No. of bedc 3.5 (±1.8) 1.53 (1.10–2.23)
Season (Feb/June vs July/January) - 0.60 (0.42–0.82) 0.53 (0.37 – 0.78)
a

- Number of swabs for each variable.

b

- REF – reference for analysis

Prevalence of pneumococcal carriage

In total, 721 swabs were collected throughout the study period, yielding 398 pneumococcal isolates. The prevalence of S. pneumoniae nasopharyngeal carriage was 50.5% (February), 46.3% (June), 63.2% (September) and 48.8% (December) at each sampling point, respectively. Of the 203 children eligible for the study, 156 (76.8%) provided nasopharyngeal samples at all four visits (Figure 1) At least one pneumococcal isolate from the nasopharyngeal sample was found in 74.4% (116 of the 156) of all children; 9.0% (14 of the 156) were not colonized at all; 19.9% (26 of the 156) were only once colonized; and 12.2% (19 of the 156) were colonized in all four visits.

Figure 1.

Figure 1

Flowchart of participants enrolled in the study.

Risk factors for colonization

Children who lived in households, where there was at least one child under two years, who lived in crowded households, and had a recent URTI in the last month had greater odds of being colonized in univariate analysis. Carriage prevalence varied in time, with decreased prevalence from February to June (dry season) compared to July to January (rainy season). Additionally, white children were less likely to be colonized than mixed children (OR, 0.52; 95% CI 0.29 – 0.93) (Table 1). From multivariate analyses shown in Table 1, prevalence of carriage varied over time, with lower prevalence occurring during dry season (OR, 0.53; 95% CI 0.37 – 0.78). Also, having contact with three or more children under two years old (OR, 2.00; 95% CI 1.33 – 2.89) and living in a house with a greater number of persons per room (OR, 1.77; 95% CI 1.05 – 3.10) were each independently and positively associated with pneumococcal carriage.

We also considered whether specific demographic risk factors were associated with having higher odds of being colonized with a highly invasive serotype or being colonized with a lower invasive serotype. Children who lived in crowded households (persons per room, persons per bed) had greater odds of being colonized by high-invasiveness serotypes. On the other hand, having had an episode of URTI in the last month increased the odds of colonization with a low-invasive serotypes. Carriage of low-invasiveness serotypes also varied over time, with a lower prevalence in the period from February to June (Table 2). Being white was associated with a lower odds of colonization with a low invasiveness serotype compared with mixed race children. However, these differences in effect sizes for the high and low invasiveness serotypes were not statistically significant.

Table 2.

Risk factors for pneumococcal carriage among children < 5 years old, stratified by invasiveness property of serotypes prior to PCV10 introduction in Brazil

Characteristics N (%) Pneumococcal Invasive property
OR (95% CI)

Low Invasivenessa
(n = 263)
High Invasivenessb
(n = 60)
Age (months)
  < 12 119 (18%) 0.74 (0.26 – 1.99) 0.18 (0.00 – 0.90)
  13–23 133 (21%) 1.54 (0.67 – 3.80) 0.57 (0.16 – 2.01)
  25–35 126 (20%) 1.09 (0.47 – 2.50) 0.48 (0.15 – 1.81)
  36–47 155 (24%) 0.76 (0.34 – 1.69) 0.61 (0.20 – 1.95)
  48–59 113 (18%) 0.82 (0.35 – 2.06) 0.40 (0.10 – 1.42)
Gender Male 312 (48%) 1.07 (0.73 – 1.55) 1.18 (0.62 – 2.25)
Race
  Mixed 452 (70%) REFc REFc
  White 52 (8%) 0.48 (0.25 – 0.89) 0.45 (0.00 – 1.28)
  Black 138 (22%) 0.70 (0.42 – 1.15) 1.31 (0.58 – 2.62)
Day-care Attendance
  No 613 (96%) REFc REFc
  Yes 25 (4%) 1.05 (0.37 – 2.80) 2.11 (0.00 – 6.34)
URTI in the last month
  No 259 (41%) REFc REFc
  Yes 375 (59%) 1.53 (1.04 – 2.24) 1.01 (0.61 – 1.70)
Exposure to cigarette smoking
  No 441 (68%) REFc REFc
  Yes 205 (32%) 0.97 (0.63 – 1.53) 1.21 (0.54 – 2.27)
Antibiotic use in the last month
  No 586 (92%) REFc REFc
  Yes 51 (8%) 0.62 (0.28 – 1.23) 1.16 (0.41 – 2.61)
Number of children ≤ 2 years living in the same household
  None 264 (41%) REFc REFc
  One contact 315 (49%) 1.38 (0.94 – 2.12) 1.95 (1.02 – 3.99)
  Two contacts 62 (9.7%) 1.92 (1.05 – 3.60) 1.60 (0.47 – 3.75)
  Three contacts 1 (0.2%) 0.00 (0.00 – 0.00) 0.00 (0.00 – 0.00)
No. of residents/No. of room 3.3 (±1.7) 1.65 (1.00 – 2.82) 2.49 (1.15 – 5.38)
No. of residents/No. of bed 3.5 (±1.8) 1.38 (0.98 – 2.07) 2.25 (1.28 – 3.89)
Season (Feb/June vs July/January) 0.57 (0.39 – 0.84) 0.68 (0.30 – 1.28)
a

- High invasiveness serotype: 4, 7F, 8, 9V, 14, 18C and 19A;

b

- Low invasiveness serotype: 3, 6A/B/C, 11A, 13, 15A, 15B/C, 16F, 17F, 19F, 20, 21, 22F, 23B, 23F, 35F and NT.

c

- REF – reference for analysis.

Serotype Distribution and Antibiotic susceptibility

Table 3 shows the distribution of serotypes recovered throughout the period of the study. The most prevalent serotypes were 6A/B (25.4%), 19F (10.1%) and, 14 (9.0%). The serotypes included in PCV10 and PCV13 accounted for 52.2% and 55.5%, respectively. The most frequent non-vaccine serotypes were 16F (4.8%), 15B/C (4.5%), 6C/D (3.5%), 34 (3%) and not typeable (7.3%); 15.3% (61/398) of the isolates of S. pneumoniae did not have the capsular type determined by multiplex-PCR. We did not find any fluctuation in the distribution of serotypes during the study period.

Table 3.

Serogroup/type distribution of all pneumococcal carriage isolates (N= 398) recovered from children < 5 years old prior to PCV10 introduction in Brazil.

Serotype No. of isolates (%)
PCV10 209 52.2
4 5 1.3
6A/B 101 25.4
7F/A 1 0.3
9V/A 2 0.5
14 36 9.0
18 10 2.5
19F 40 10.1
23F 14 3.5
PCV13 221 55.5
3 7 1.8
19A 5 1.3
Non-vaccine 177 44.5
6C/D 14 3.5
8 1 0.3
11A 4 1.0
13 5 1.0
15A 2 0.6
15B/C 18 4.5
16F 19 4.8
17F 2 0.6
20 2 0.6
21 3 0.8
22F/A 2 0.6
23B 1 0.3
34 12 3.0
35B 1 0.3
35F 1 0.3
ND a 61 15.3
NTb 29 7.3
a

ND= Not Determined by Multiplex PCR.

b

NT=Not typeable by both methods (Multiplex PCR and Quellung Reaction)

Overall, 38.4% (153/398) of the pneumococci were non-susceptible to penicillin, with MICs ranging from 0.12 to 8.0 µg/ml. The percentage of capsular types included in the PCV10 vaccine among penicillin non-susceptible accounted for 73.2% (112/153) as follows: 6A/B (45/112; 40%), 19F (29/112; 25.9%), 14 (20/112; 18%), 23F (12/112; 11%) and others (6/112; 5%). The non-vaccine serotypes commonly associated with penicillin non-susceptibility (41/153; 22%) were: NT (6/41; 14.6%), 16F (4/41; 9.8%), 13 (3/41; 7.3%), 21 (3/41; 7.3%), 34 (1/41; 2.4%). In addition, 58% (231/398) were non-susceptible to TMP/SMX, 18.6% (74/398) to tetracycline, 3% (12/398) to erythromycin, and 2% (8/398) to cefotaxime. Of the 153 penicillin non-susceptible isolates, 113 (73.8%) were also non susceptible to TMP/SMX. The drugs involved in the most frequently identified patterns of multidrug nonsusceptibility, defined as being intermediate or resistant to three or more classes of antibiotics, were penicillin, TMP/SMX and tetracycline (14 of 398 isolates), penicillin, TMP/SMX and erythromycin (7 of 398 isolates), penicillin, TMP/SMX, cefotaxime (3 of 398 isolates) and penicillin, TMP/SMX, cefotaxime, and erythromycin (3 of 398 isolates).

Genotyping

PFGE analysis confirmed that 24 of the 156 (15.4%) children were highly likely to have been colonized by the same pneumococcal PFGE type at multiple time points: 6A/B (n=9/24; 37.5%), 14 (n=5/24; 20.8%), 19F (n=4/24; 16.7%), 34 (n=2/24; 8.3%), 23F (n=1/24; 4.2%), 3 (n=1/24; 4.2%), 6C (n=1/24; 4.2%) and 15B/C (n=1/24; 4.2%). The most commonly identified sequence types were ST156 (14;[n=5]), ST 66 (14;[n=10]), ST177 (19F; [n=7]), ST 338 (23F;[n=6]), ST 3930 (6C; [n=3]) and ST 771 (34; [n=4]). Strains belonging to the ST 66, ST 156 and ST 177 were isolated more than once in the same child, indicating persistence in the environment for up to six months.

Discussion

We found carriage prevalence of 55% with temporal fluctuations, with lower prevalence of carriage occurring in the period from February to June. Temporal variation was not observed in a previous study conducted in England in a period of ten months [19] but was observed among Navajo children [20]. As has been reported [19, 21], higher carriage rates are observed in children less than 5 years of age. The younger the patient, the greater the chance of pneumococcal colonization [22]. Although, variability in carriage rates were not observed in different age groups from this study population, in general, the observed carriage rate is in agreement with previous studies conducted in others Brazilian cities [7, 23].

In Brazil, as in many developing countries, a significant proportion of the population lives in slum communities [24]. These urban informal settlement, characterized by crowded households and lower incomes, have been identified as factors associated with increased pneumococcal carriage in children [25]. The household density phenomenon of pneumococcal disease and carriage has been discussed in previous studies [22, 25, 26]. In this cohort study, conducted in an urban community, the prevalence of pneumococcal carriage increased with increasing household density. Furthermore, we have identified that in this community, living in a crowded home (as defined by the number of household contacts with other children, the number of people per bed, or number of people per room) is associated with an increased risk for being colonized with pneumococcus. Households in Brazilian’ slums are very small in size and can be overcrowded with as many as 5 persons per room [11].

This study suggests that having a URTI in the last month increases the odds of being colonized, although not statistically significant. In addition, URTI also trended towards increasing the odds of carriage pneumococcal serotypes of lower invasiveness potential. Another study showed that influenza co-infection was associated with the greatest increases in the incidence of URTI caused by pneumococcal serotypes of lower invasiveness potential [27]. Unfortunately, we have not done laboratory diagnosis of influenza in this population to further explore this association.

The serotype distribution among nasopharyngeal isolates in the present study was similar to that found in previous studies in Brazil [79, 23] and other countries in Latin America and Europe [28, 29]. Overall, the serotypes isolated from the nasopharynx included the most common serotypes causing invasive disease [30] and represented in the PCV-10 vaccine (~ 52%). No significant additional protection against carriage was provided by the PCV-13 formulation of the vaccine, as the two additional serotypes (3 and 19A) represented only 3% of carriage isolates. In Brazil, PCV13 is only available in private clinics at a high cost (about US$ 100/dose). The most common non-vaccine serotypes found in this study (16F, 15B/C, 6C and 34) are rarely associated with invasive disease in Salvador [30]. However, some of these non-vaccine serotypes (34 and 15B / C) are successful in carriage, with persistent carriage in the same children for up to six months. Other studies of colonization identified a high prevalence of those serotypes [21, 31], and these findings might indicate the possibility of serotype replacement, as observed in others places after PCV7 introduction [32, 33].

The rates of antimicrobial resistance observed in this study population were higher for both penicillin non-susceptible and SXT than previously shown in another colonization study conducted in Salvador [9]. Likewise, increasing resistance has already been documented in invasive disease in Salvador, with rates growing from 15% (1999) to 22.2% (2007) [30, 34]. Geographical variations in the frequency of antibiotic resistance have been observed in different regions of Brazil and others countries [7, 23, 35, 36], and these differences may reflect, in part, true geographical differences in antibiotic resistance rate, but most likely reflect differences due to investigation methodology and populations sampled.

We also identified carriage of internationally spread clones of pneumococci with penicillin non-susceptibility as the ST66, 156, 177. All of these clones have been associated with carriage and invasive disease in Salvador and others places [6, 32]. In this community, these clones also account for persistent carriage, having been identified in the same child at intervals up to six months. Swabbing every 3 months is unlikely to detect the same S. pneumoniae carriage episode, as a recent Kenyan study described the mean duration of carriage to be 30-days [37]. A study conducted in Gambia showed that serotype 14 had longer duration of carriage [38]. In this study community, the serotypes 6A/B, 14 and 19F were isolated in the same child in more than one visit during the year.

There are some limitations to the study. Firstly, nasopharyngeal swabs were not taken in monthly intervals; the monthly intervals between nasopharyngeal swabs improves detection of serotypes carried for short durations and assessment of persistence of carriage. Secondly, we used the World Health Organization culture protocol that underestimates the prevalence of multiple serotype carriage. Thus, we must have identified the predominant serotype, missing the minor carried ones. Also, we did not discriminate between serotypes 6A from 6B, considering both as a PCV-10 serotype. In addition, the serotypes identified as highly invasive were chosen based upon a single study from the UK and that that invasive serotypes 1 and 5 which are often associated with IPD in children were not detected in this study. However, invasiveness patterns among serotypes are generally consistent worldwide [39]. Finally, the loss of follow-up, which is a major problem in cohort studies, did not affect the analysis, since the risk of been colonized was considered for all children.

This study provides baseline information on pneumococcal carriage that may be particularly relevant for monitoring and evaluation of the PCV-10 vaccine, which was introduced in the Brazilian Immunization Program in March 2010. This vaccine would have a considerably impact on asymptomatic carriage among children throughout the community (52.2%). Our study´s findings indicate that conditions of high density, as happens in houses of slum settlements in Brazil, could have a relevant role in community transmission of pneumococcus. Serotype shift and replacement, together with clonal expansion of pneumococci with non-vaccine serotypes, have been noted in other countries following the introduction of pneumococcal conjugate vaccine and may become major concerns. Thus the contribution of these crowded communities in keeping non-vaccine serotypes circulating, and their ability to cause invasive disease should be monitored after introduction of conjugate vaccines.

Acknowledgments

We would like to thank all the community members in Salvador who participated in the study. We also thank Milena Soares and Soraia Machado Cordeiro for advice during laboratory analysis.

This work was supported by grants from the Brazilian National Research Council (482755/2010-5), the Research Foundation for the State of Bahia (FAPESB: 1431040054051) and the National Institutes of Health (TW007303). DMW is supported by the Global Health Equity Scholars training program (TW009338), The Bill and Melinda Gates Foundation (OPP1114733), the Yale Program on Aging (P30AG021342), and NIH/NIAID (R56 AI110449)

Conflicts of Interest

DMW is the Principal Investigator of an Investigator Initiated Research grant from Pfizer to Yale University and has received consulting fees from Merck and Pfizer.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Disclaimers: The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the Centers for Disease Control and Prevention or the institutions with which the authors are affiliated.

Author Contributions

Conceived and designed the experiments: JNR, AK, MGC. Performed the experiments: APOM, MGC. Collect the samples: APOM, JA, LCC, MCL, JNR. Analyzed the data: APOM, MC,DW, GR. Contributed reagents/materials/analysis tools: JNR, MR, MGC. Wrote the paper: JNR, APOM, GR, DW. Reviewed and revised the final version of the manuscript: All authors.

References

  • 1.Zhang Q, Arnaoutakis K, Murdoch C, et al. Mucosal immune responses to capsular pneumococcal polysaccharides in immunized preschool children and controls with similar nasal pneumococcal colonization rates. Pediatr Infect Dis. 2004;23:307–313. doi: 10.1097/00006454-200404000-00006. [DOI] [PubMed] [Google Scholar]
  • 2.Turner P, Melchiorre S, Moschioni M, et al. Assessment of Streptococcus pneumoniae pilus islet-1 prevalence in carried and transmitted isolates from mother-infant pairs on the Thailand-Burma border. Clin Microbiol Infect. 2011;18(2):970–975. doi: 10.1111/j.1469-0691.2011.03711.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Valente C, de Lencastre H, Sá-Leão R. Selection of Distinctive Colony Morphologies for Detection of Multiple Carriage of Streptococcus pneumoniae. Pediatr Infect Dis J. 2013;32:703–704. doi: 10.1097/INF.0b013e31828692be. [DOI] [PubMed] [Google Scholar]
  • 4.Shak JR, Vidal JE, Klugman KP. Influence of bacterial interactions on pneumococcal colonization of the nasopharynx. Trends Microbiol. 2013;21:129–135. doi: 10.1016/j.tim.2012.11.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Pilishvili T, Lexau C, Farley MM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J. Infect Dis. 2010;201:32–41. doi: 10.1086/648593. [DOI] [PubMed] [Google Scholar]
  • 6.Miller E, Andrews NJ, Waight PA, et al. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis. 2011;11:760–768. doi: 10.1016/S1473-3099(11)70090-1. [DOI] [PubMed] [Google Scholar]
  • 7.Pimenta FC, Carvalho MdaG, Gertz RE, Jr, et al. Serotype and genotype distributions of pneumococcal carriage isolates recovered from Brazilian children attending day-care centres. J Med Microbiol. 2011;60:1455–1459. doi: 10.1099/jmm.0.031450-0. [DOI] [PubMed] [Google Scholar]
  • 8.Berezin EN, Cardernuto MD, Ferreira LL, et al. Distribution of Streptococcus pneumoniae serotypes in nasopharyngeal carriage and in invasive pneumococcal disease in Sao Paulo, Brazil. Pediatr Infect Dis J. 2007;26:643–645. doi: 10.1097/INF.0b013e3180616d0f. [DOI] [PubMed] [Google Scholar]
  • 9.Reis JN, Palma T, Ribeiro GS, et al. Transmission of Streptococcus pneumoniae in an urban slum community. J Infect. 2008;57:204–213. doi: 10.1016/j.jinf.2008.06.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Instituto Brasileiro de Geografia e Estatística (IBGE) Subnormal Agglomerates - First Results. In: Rio de Janeiro: Estatística IBGE, editor. 2010. pp. 1–259. [Google Scholar]
  • 11.Reis RB, Ribeiro GS, Felzembergh RD, et al. Impact of Environment and Social Gradient on Leptospira Infection in Urban Slums. Plos Infected Tropical Diseases. 2008;2:1–10. doi: 10.1371/journal.pntd.0000228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Carvalho MdaG, Pimenta FC, Jackson D, et al. Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes. J Clin Microbiol. 2010;48:1611–1618. doi: 10.1128/JCM.02243-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Menezes APdeO, Reis JN, Ternes YM, et al. Update of pneumococcal PCR serotyping assay for detection of a commonly occurring type 19F wzy variant in Brazil. J Clin Microbiol. 2013;51:2470–2471. doi: 10.1128/JCM.00743-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Clinical Laboratory Standards Institute. 17th Informational Supplement. CLSI document M100-S21. 1. Vol. 31. Wayne, PA: NCCLS; 2011. Performance Standards for antimicrobial susceptibility testing; Twenty-First International Supplement. [Google Scholar]
  • 15.Lefevre JC, Faucon G, Sicard A, Gasc AM. DNA fingerprinting of Streptococcus pneumoniae strains by pulsed-field gel electrophoresis. J Clin Microbiol. 1993;30:2724–2728. doi: 10.1128/jcm.31.10.2724-2728.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Enright MC, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae identification of clones associated with serious invasive disease. Microbiology. 1998;144:3049–3060. doi: 10.1099/00221287-144-11-3049. [DOI] [PubMed] [Google Scholar]
  • 17.Burnham KP, Anderson DR. Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach. 2nd. Springer-Verlag; 2002. ISBN 0-387-95364-7. [Google Scholar]
  • 18.Sleeman KL, Griffiths D, Shackley F, et al. Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis. 2006;194:682–688. doi: 10.1086/505710. [DOI] [PubMed] [Google Scholar]
  • 19.Hussain M, Melegaro A, Pebody RG, et al. A longitudinal household study of Streptococcus pneumoniae nasopharyngeal carriage in a UK setting. Epidemiol Infect. 2005;133:891–898. doi: 10.1017/S0950268805004012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Weinberger DM, Grant LR, Steiner CA, et al. Seasonal drivers of pneumococcal disease incidence: impact of bacterial carriage and viral activity. Clin Infect Dis. 2014;58:188–194. doi: 10.1093/cid/cit721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Hare KM, Singleton RJ, Grimwood K, et al. Longitudinal nasopharyngeal carriage and antibiotic resistance of respiratory bacteria in indigenous Australian and alaska native children with bronchiectasis. PLoS One. 2013;8:1–9. doi: 10.1371/journal.pone.0070478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Hsu KK, Rifas-Shiman SL, Shea KM, et al. Do community-level predictors of pneumococcal carriage continue to play a role in the conjugate vaccine era? Epidemiol Infect. 2014;142:379–387. doi: 10.1017/S0950268813000794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Neves FPG, Pinto TCA, Corrêa MA, et al. Nasopharyngeal carriage serotype distribution and antimicrobial resistance of Streptococcus pneumoniae among children from Brail before introduction of the 10-valent conjugate vaccine. BMC Infections Disease. 2013;13:1–7. doi: 10.1186/1471-2334-13-318. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Sclar ED, Garau P, Carolini G. The 21st century health challenge of slums and cities. Lancet. 2005;365:901–903. doi: 10.1016/S0140-6736(05)71049-7. [DOI] [PubMed] [Google Scholar]
  • 25.Huang SS, Finkelstein JA, Rifas-Shiman SL, Kleinman K, Platt R. Community-level predictors of pneumococcal carriage and resistance in young. Am. J. Epidemiol. 2004;154:645–654. doi: 10.1093/aje/kwh088. [DOI] [PubMed] [Google Scholar]
  • 26.Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonization: the key to pneumococcal diseases. Lancet Infect Dis. 2004;4:144–154. doi: 10.1016/S1473-3099(04)00938-7. [DOI] [PubMed] [Google Scholar]
  • 27.Weinberger DM, Harboe ZB, Viboud C, et al. Serotype-specific effect of influenza on adult invasive pneumococcal pneumonia. J Infect Dis. 2013;208:1274–1280. doi: 10.1093/infdis/jit375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Rodrigues F, Foster D, Caramelo F, et al. Progressive changes in pneumococcal carriage in children attending daycare in Portugal after 6 years of gradual conjugate vaccine introduction show falls in most residual vaccine serotypes but no net replacement or trends in diversity. Vaccine. 2012;30:3951–3956. doi: 10.1016/j.vaccine.2012.03.058. [DOI] [PubMed] [Google Scholar]
  • 29.Rivera-Olivero IA, del Nogal B, Sisco MC, et al. Carriage and invasive isolates of Streptococcus pneumoniae in Caracas, Venezuela: the relative invasiveness of serotypes and vaccine coverage. Eur J Clin Microbiol Infect Dis. 2011;30:1489–1495. doi: 10.1007/s10096-011-1247-5. e. [DOI] [PubMed] [Google Scholar]
  • 30.Menezes APdeO, Campos LC, dos Santos MS, et al. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae prior to introduction of the 10-valent pneumococcal conjugate vaccine in Brazil, 2000–2007. Vaccine. 2011;29:1139–1144. doi: 10.1016/j.vaccine.2010.12.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ercibengoa M, Arostegi N, Marimon JM, et al. Dynamics of pneumococcal nasopharyngeal carriage in healthy children attending a day care center in northern Spain. Influence of detection techniques on the results. BMC Infect Dis. 2012;12:69. doi: 10.1186/1471-2334-12-69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Isaacman DJ, Mclntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis. 2010;14:197–209. doi: 10.1016/j.ijid.2009.05.010. [DOI] [PubMed] [Google Scholar]
  • 33.Hicks LA, Harrison LH, Flannery B, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004. J Infect Dis. 2007;196:1346–1354. doi: 10.1086/521626. [DOI] [PubMed] [Google Scholar]
  • 34.Reis JN, Cordeiro SM, Coppola SJ, et al. Population-based Survey of Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae from Meningitis patients in Salvador, Brazil. J Clin Microbiol. 2002;40:275–277. doi: 10.1128/JCM.40.1.275-277.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Volonakis K, Souli M, Kapaskelis A, et al. Evolution of resistance patterns and identification of risk factors for Streptococcus pneumoniae colonization in daycare centre attendees in Athens, Greece. Int J Antimicrob Agents. 2006;301:297–301. doi: 10.1016/j.ijantimicag.2006.07.002. [DOI] [PubMed] [Google Scholar]
  • 36.Andrade AL, Franco CM, Lamaro-Cardoso J, et al. Non-typeable Streptococcus pneumoniae carriage isolates genetically similar to invasive and carriage isolates expressing capsular type 14 in Brazilian infants. J Infect. 2010;61:314–322. doi: 10.1016/j.jinf.2010.07.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Abdullahi O, Karani A, Tigoi CC, et al. The prevalence and risk factors for pneumococcal serotypes in the nasopharynges of children in Kilifi District, Kenya. Plos One. 2012;7:1020–1029. doi: 10.1371/journal.pone.0030787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Hill PC, Cheung YB, Akisanya A, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study. Clin Infect Dis. 2008;46:807–814. doi: 10.1086/528688. [DOI] [PubMed] [Google Scholar]
  • 39.Brueggemann AB, Peto TEA, Crook DW, Butler JC, Kristinsson KG, Spratt BG. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis. 2004;190:1203–1211. doi: 10.1086/423820. [DOI] [PubMed] [Google Scholar]

RESOURCES